Skip to Main Content

Author Details

Michael Morrissey
1996
19
16
PMIDPaper TitleJournal TitlePublished Year
34965943Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types.Clin Cancer Res2022
30667365Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials.Endocr Relat Cancer2019
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
30643118Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.Nat Commun2019
31285372Use of Circulating Tumor DNA for Cancer Immunotherapy.Clinical Cancer Research2019
31068700Next-generation characterization of the Cancer Cell Line Encyclopedia.Nature2019
30275569Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.Nat Med2018
30327465Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.Nat Commun2018
27999612PureCN: copy number calling and SNV classification using targeted short read sequencing.Source Code Biol Med2016
27148582Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus.Cold Spring Harb Mol Case Stud2016
27159400Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.JAMA Neurol2016
25524945The identification and characterization of a STAT5 gene signature in hematologic malignancies.Cancer Biomark2015
24362935Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma.Nat Med2014
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
20530672The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells.Cancer Research2010
20881279Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.Sci Transl Med2010
17452456Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.Molecular and Cellular Biology2007
10500170Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates.Proc Natl Acad Sci U S A1999
9080185Design of proteins with selected thermal properties.Fold Des1996
  • 1 - 19 of 19

Recommended Authors

Collaborators

Markus Riester
Novartis Institutes for BioMedical Research
Co-authored papers 6
Wendy Winckler
Co-authored papers 6
Jordi Barretina
Co-authored papers 5
John E Monahan
Co-authored papers 5
Scott Mahan
Co-authored papers 5
William R Sellers
Co-authored papers 5
Markus Warmuth
Co-authored papers 4
Rebecca J Leary
Co-authored papers 4
Dmitriy Sonkin
National Cancer Institute
Co-authored papers 4
Robert Schlegel
Co-authored papers 4
Michael D Jones
Co-authored papers 4
Barbara L Weber
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 4
Nicolas Stransky
Co-authored papers 3
Judit Jané-Valbuena
Co-authored papers 3
Anupama Reddy
Co-authored papers 3
Gregory V Kryukov
Co-authored papers 3
Giordano Caponigro
Co-authored papers 3
Joseph Lehár
Co-authored papers 3
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 3
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 3
Manway Liu
Verily Life Sciences LLC
Co-authored papers 3
Kavitha Venkatesan
Co-authored papers 3
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 3
Jill P Mesirov
University of California San Diego
Co-authored papers 2
Michael F Berger
Co-authored papers 2
Adam Korejwa
Co-authored papers 2
Jiebiao Wang
Co-authored papers 2
William R Sellers
Co-authored papers 2
Lauren Murray
Co-authored papers 2
Matthew Meyerson
Broad Institute
Co-authored papers 2
Release 1.2